Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Sign up for the iNFOnews newsletter today!
Selecting your primary region ensures you get the stories that matter to you first.

TORONTO – Angelina Jolie’s bombshell revelation of her double mastectomy due to a genetic cancer risk has brought renewed attention to specific genes linked to the development of both breast and ovarian cancers.
The Oscar winner revealed in an op-ed piece published in the New York Times that she carries the BRCA1 gene and opted to remove her breasts as a preventive measure.
University of Toronto associate professor Kelly Metcalfe said if women are found to have mutations of the BRCA1 and BRCA2 genes, they have a very high risk of developing breast cancer and ovarian cancer.
Metcalfe said those risks can change depending on the woman’s personal situation in terms of her age and family history.
Metcalfe said there are certain criteria an individual must meet to be eligible for genetic testing, which involves personal and family histories of cancer.
Individuals who don’t meet the criteria can have genetic testing done in the U.S. for about $3,000.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.